People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
At 2cureX, we’re pioneers of 3D microtumors in cancer therapy, focused on improving the outcomes of cancer treatment
2cureX launches IndiTreat® for metastasised colon cancer, the world’s first CE validated IVD based on microtumors
Life Science Investor Konference, Copenhagen
2cureX Interim Report Q3 2020
View previous reports
Redeye Life Science Day, Stockholm
2cureX Year-End Report 2020
IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.